Cargando…

Prognostic Impact of the Early Use of Tolvaptan in Elderly Patients with Acute Decompensated Heart Failure

The number of elderly patients with acute decompensated heart failure (ADHF) is increasing, and it is often difficult to treat. This study aimed to evaluate the efficacy and safety of using tolvaptan early after hospitalization in elderly patients with ADHF and the prognosis one year after hospitali...

Descripción completa

Detalles Bibliográficos
Autores principales:	Okada, Tomoaki, Miyoshi, Toru, Oka, Akihiro, Tsushima, Ryu, Sudo, Yuya, Seiyama, Kosuke, Takagi, Wataru, Kawaguchi, Tomohiro, Ozaki, Masatomo, Sogo, Masahiro, Ugawa, Satoko, Nosaka, Kazumasa, Takahashi, Masahiko, Okawa, Keisuke, Doi, Masayuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10179179/ https://www.ncbi.nlm.nih.gov/pubmed/37176546 http://dx.doi.org/10.3390/jcm12093105

Ejemplares similares

Fulminant myocarditis after the second dose of COVID‐19 mRNA vaccination
por: Oka, Akihiro, et al.
Publicado: (2022)

Effect of Early Initiation of Evolocumab on Lipoprotein(a) in Patients with Acute Myocardial Infarction: Sub-Analysis of a Randomized Controlled Trial
por: Okada, Tomoaki, et al.
Publicado: (2022)

Secular Decreasing Trend in Plasma Eicosapentaenoic and Docosahexaenoic Acids among Patients with Acute Coronary Syndrome from 2011 to 2019: A Single Center Descriptive Study
por: Okada, Tomoaki, et al.
Publicado: (2021)

A successful transfemoral transcatheter aortic valve replacement case with VIABAHN® VBX balloon‐expandable stent‐graft and long Dryseal sheath for challenging access route
por: Kawaguchi, Tomohiro, et al.
Publicado: (2023)

Serial changes in the trends of direct oral anticoagulant use and incidence of thromboembolisms and major bleeding events in very old patients with non-valvular atrial fibrillation
por: Takahashi, Masahiko, et al.
Publicado: (2023)

Relationship Between Endothelial Dysfunction and the Outcomes After Atrial Fibrillation Ablation
por: Okawa, Keisuke, et al.
Publicado: (2023)

Cardiovascular events and death after catheter ablation in very old patients with nonvalvular atrial fibrillation
por: Okawa, Keisuke, et al.
Publicado: (2023)

Lotus root‐like appearance in the left anterior descending artery treated with a drug‐coated balloon angioplasty
por: Takagi, Wataru, et al.
Publicado: (2022)

Long-term administration of Tolvaptan to patients with decompensated cirrhosis
por: Kanayama, Kengo, et al.
Publicado: (2020)

Circulating adipocyte fatty acid-binding protein is a predictor of cardiovascular events in patients with stable angina undergoing percutaneous coronary intervention
por: Takagi, Wataru, et al.
Publicado: (2017)

Successful coronary stent implantation using directional coronary atherectomy without side branch occlusion
por: Kawaguchi, Tomohiro, et al.
Publicado: (2023)

Impact of chronic kidney disease on the diuretic response of tolvaptan in acute decompensated heart failure
por: Ikeda, Shuntaro, et al.
Publicado: (2017)

Risk and protective factors of acute kidney injury in decompensated cirrhotic patients with ascites on tolvaptan
por: Kogiso, Tomomi, et al.
Publicado: (2021)

Clinical utility of early use of tolvaptan in very elderly patients with acute decompensated heart failure
por: Niikura, Hiroki, et al.
Publicado: (2017)

Tolvaptan in the very elderly with acute decompensated heart failure-a therapeutic option worth of consideration
por: Ndrepepa, Gjin
Publicado: (2017)

Renoprotective Benefit of Tolvaptan in Acute Decompensated Heart Failure Patients With Loop Diuretic-Resistant Status
por: Yamamoto, Tomohiko, et al.
Publicado: (2019)

Tolvaptan
por: Rangarajan, Bharath, et al.
Publicado: (2014)

THU239 Tolvaptan For SIADH Management In Children
por: Igarashi, Mizuho, et al.
Publicado: (2023)

Serum Copeptin and Zinc-α2-glycoprotein Levels Are Novel Biomarkers of Tolvaptan Treatment in Decompensated Cirrhotic Patients with Ascites
por: Shigefuku, Ryuta, et al.
Publicado: (2021)

Efficacy of tolvaptan for the patients with advanced hepatocellular carcinoma
por: Miyazaki, Masayuki, et al.
Publicado: (2017)

Renoprotection by long‐term low‐dose tolvaptan in patients with heart failure and hyponatremia
por: Oka, Tatsufumi, et al.
Publicado: (2021)

Effects of tolvaptan on urine output in hospitalized heart failure patients with hypoalbuminemia or proteinuria
por: Takagi, Koji, et al.
Publicado: (2017)

Tolvaptan-induced hypernatremia related to low serum potassium level accompanying high blood pressure in patients with acute decompensated heart failure
por: Fukuoka, Hidetada, et al.
Publicado: (2020)

Tolvaptan- and Tolvaptan-Metabolite-Responsive T Cells in Patients with Drug-Induced Liver Injury
por: Gibson, Andrew, et al.
Publicado: (2020)

Tolvaptan for the Treatment of Enlarged Polycystic Liver Disease
por: Mizuno, Hiroki, et al.
Publicado: (2017)

Tolvaptan, hyponatremia, and heart failure
por: Zmily, Hammam D, et al.
Publicado: (2011)

Tolvaptan for the Treatment of Refractory Ascites
por: Kurosaki, Masayuki, et al.
Publicado: (2016)

Adding High-Dose Spironolactone to Tolvaptan Improves Acute Decompensated Heart Failure Due to Obstructive Hypertrophic Cardiomyopathy and Aortic Stenosis: A Case Report
por: Kajimoto, Katsuya, et al.
Publicado: (2019)

Predictors of in-hospital mortality in elderly patients with heart failure treated with tolvaptan
por: Kobayashi, Masakazu, et al.
Publicado: (2023)

Successful Medical Treatment Using Tolvaptan of Ventricular Septal Rupture Following Myocardial Infarction
por: Terada, Kazushi, et al.
Publicado: (2017)

Potential effect of tolvaptan on polycystic liver disease for patients with ADPKD meeting the Japanese criteria of tolvaptan use
por: Mizuno, Hiroki, et al.
Publicado: (2022)

Tolvaptan and its potential in the treatment of hyponatremia
por: Dixon, Megan B, et al.
Publicado: (2008)

V2 Receptor Antagonist; Tolvaptan
por: Yi, Joo-Hark, et al.
Publicado: (2011)

Predictors of the Effect of Tolvaptan on the Prognosis of Cirrhosis
por: Iwamoto, Takuya, et al.
Publicado: (2016)

The management of polycystic liver disease by tolvaptan
por: Takenaka, Tsuneo, et al.
Publicado: (2020)

Tolvaptan for the Treatment of Elephantiasis Nostras Verrucosa
por: Eda, Yuko, et al.
Publicado: (2019)

Early initiation of tolvaptan is associated with early discharge in patients with heart failure regardless of age
por: Kiuchi, Shunsuke, et al.
Publicado: (2022)

Prognostic Effect of a Novel Simply Calculated Nutritional Index in Acute Decompensated Heart Failure
por: Ishiwata, Sayaki, et al.
Publicado: (2020)

Elevated serum adipocyte fatty acid-binding protein concentrations are independently associated with renal dysfunction in patients with stable angina pectoris
por: Iwamoto, Mutsumi, et al.
Publicado: (2012)

AN69ST membranes adsorb nafamostat mesylate and affect the management of anticoagulant therapy: a retrospective study
por: Hirayama, Takahiro, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ubochpuis8dpgo66lntjnt8t4e